phosphatidic acid
Small moleculeexperimental
Phosphatidic acids are anionic phospholipids important to cell signaling and direct activation of lipid-gated ion channels. Hydrolysis of phosphatidic acid gives rise to one molecule each of glycerol and phosphoric acid and two molecules of fatty acids. They constitute about 0.25% of phospholipids in the bilayer. — Wikipedia
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 31, 2015 (NCT03446924)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPhosphatidic acid ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04277364 | N/A | Feb 16, 2020 | University of Sao Paulo |
| NCT03446924 | N/A | Aug 31, 2015 | University of Birmingham, University of Nottingham |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Birmingham | Academic/Hospital | 1 | 1 | 1 | 2015 |
| University of Nottingham | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Sao Paulo | Academic/Hospital | 1 | 1 | 1 | 2020 |
3 organizations
Page 1 / 1